At the Inflection Point of Healthcare Technology
MRX Innovations is actively engaging strategic investors and medical device partners who understand the magnitude of this transformation. The convergence of AI and XR in clinical medicine is not a future possibility — it is happening now.
01 — The Opportunity
A $84 Billion Market in Transformation
The global medical XR market is projected to reach $84 billion by 2030, driven by the convergence of AI diagnostics, spatial computing, and the accelerating digitisation of clinical workflows. MRX Innovations is positioned at the centre of this transformation — with the platform, the partnerships, and the regulatory pathway to capture a defining share.
$84B
Addressable market by 2030
47%
Projected CAGR
2.4B+
Patients who could benefit
2026
Target commercial launch
02 — Pipeline
A Clear Path to Commercial Scale
Founded
MRX Innovations incorporated. Core AI engine development begins.
Seed Round
$12M seed round closed. First clinical partnerships established.
FDA Breakthrough
FDA Breakthrough Device designation received for AI diagnostic module.
Series A
$45M Series A. Platform expanded to full XR suite. 40+ clinical sites.
CE Mark
CE Mark certification achieved. European commercial pathway opened.
Series B
$120M Series B target. Scaling to 500+ clinical sites globally.
Commercial Launch
Full commercial launch across North America, Europe, and APAC.
03 — Why Now
The Conditions for Transformation Are Aligned
Regulatory Clarity
FDA and CE frameworks for AI medical devices are now established. The regulatory pathway is clear and precedented.
Hardware Maturity
XR hardware has reached the performance threshold required for clinical deployment — latency, precision, and form factor are all viable.
Clinical Demand
Post-pandemic healthcare systems are under unprecedented pressure. AI and XR offer the only scalable path to improved outcomes with constrained resources.
Data Infrastructure
EHR adoption and FHIR interoperability standards mean clinical data is now accessible at the scale required to train and validate AI models.
04 — Connect
Join the XR Medical Revolution
We are actively engaging strategic investors, medical device partners, and institutional healthcare systems. Complete the form and our investor relations team will respond within 24 hours.